Ensign Group director Shaw Daren sells $283k in company stock

Published 19/08/2024, 22:20
Ensign Group director Shaw Daren sells $283k in company stock

Investors tracking insider transactions at Ensign Group, Inc (NASDAQ:ENSG) may note that director Shaw Daren recently sold shares in the company. The transaction, which took place on August 15, 2024, involved the sale of 2,000 shares of Ensign Group common stock at a price of $141.71 per share, totaling approximately $283,420.

This sale was conducted under a pre-arranged trading plan, known as a Rule 10b5-1 plan, which Shaw had adopted on May 6, 2024. Such plans allow company insiders to sell a predetermined number of shares at a predetermined time, providing an affirmative defense against accusations of trading on nonpublic information.

Following this transaction, Shaw Daren's ownership in the skilled nursing facilities operator stands at 29,125 shares of common stock. The transaction was signed off by Chad A. Keetch, as power of attorney, on August 19, 2024.

It is not uncommon for executives and directors to sell portions of their stock holdings for various reasons, and such sales do not necessarily indicate a lack of confidence in the company's future prospects. Investors often look at insider sales and purchases as one of many indicators to inform their investment decisions.

Ensign Group, headquartered in San Juan Capistrano, California, operates in the healthcare sector providing services including skilled nursing and rehabilitative care services.

In other recent news, The Ensign Group (NASDAQ:ENSG), Inc. reported a record-setting second quarter for 2024, marked by increased occupancy and revenue, and raised its annual earnings and revenue guidance. The company's same-store occupancy climbed to 80.8%, a 2.8% increase year-over-year, and it acquired 10 new operations and six real estate assets. This expansion added 1,326 skilled nursing beds, 202 senior living units, and 43 LTACH beds to their portfolio.

Ensign Group's annual earnings guidance was raised to $5.38 to $5.50 per diluted share, with revenue guidance adjusted to $4.20 billion to $4.22 billion. The company's Arrowhead Springs Healthcare in California improved from a 3-star to a 5-star CMS rating, and Rainier Rehabilitation in Washington saw a 17% revenue increase and a 34% EBIT increase year-over-year.

Ensign Group also plans to expand into new states, with a focus on growing clusters, particularly in Tennessee. Despite a legal battle against the minimum staffing rule, the company remains confident in its legal position and does not expect rate setting to change following the overturning of the Chevron (NYSE:CVX) doctrine. These are among the most recent developments for the company.

InvestingPro Insights

As investors consider the implications of insider transactions at Ensign Group, Inc (NASDAQ:ENSG), understanding the company's financial health and market performance can provide a broader context. According to InvestingPro data, Ensign Group currently boasts a robust market capitalization of $8.03 billion. The company's solid revenue growth is reflected in a 17.12% increase over the last twelve months as of Q2 2024, with a gross profit margin of 16.17% indicating its efficiency in managing production costs relative to sales.

Despite the insider sale, Ensign Group's stock has experienced a strong return over the last three months, with a price total return of 17.97%. This positive performance is consistent with the company's long-term trend, as indicated by an impressive return of 45.94% over the past year. Moreover, Ensign Group has demonstrated a commitment to shareholder returns, raising its dividend for 18 consecutive years, a testament to its financial stability and confidence in future growth.

InvestingPro Tips also highlight that four analysts have revised their earnings estimates upwards for the upcoming period, suggesting potential optimism about the company's earnings trajectory. Additionally, the company is noted for its low price volatility, providing a relatively stable investment option in the healthcare sector.

For investors seeking more in-depth analysis, InvestingPro offers additional tips on Ensign Group, which can be accessed at https://www.investing.com/pro/ENSG. These insights include evaluations of the company's earnings multiples, cash flow capabilities, and valuation metrics, among others, to help investors make more informed decisions.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.